Alcohol, Drugs and Addictive Behaviours
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.

Screening and brief intervention for alcohol problems in primary health care

 

BACKGROUND

There are many forms of excessive drinking that cause substantial risk or harm to the individual. They include high level drinking each day, repeated episodes of drinking to intoxication, drinking that is actually causing physical or mental harm, and drinking that has resulted in the person becoming dependent on alcohol. Excessive drinking causes illness and distress to the drinker and his or her family and friends. It is a major cause of breakdown in relationships, trauma, hospitalization, prolonged disability and early death. Alcohol-related problems represent an immense economic loss to many communities around the world. 

 

Screening for alcohol use: why AUDIT?

The AUDIT was developed as a simple method of screening for excessive drinking and to assist in brief assessment. It can help identify excessive drinking as the cause of the presenting illness. It provides a framework for intervention to help risky drinkers reduce or cease alcohol consumption and thereby avoid the harmful consequences of their drinking. The AUDIT also helps to identify alcohol dependence and some specific consequences of harmful drinking. Of utmost importance for screening is the fact that people who are not dependent on alcohol may stop or reduce their alcohol consumption with appropriate assistance and effort. The manual is particularly designed for health care practitioners and a range of health settings, but with suitable instructions it can be self-administered or used by non-health professionals. 

Screening for alcohol consumption among patients in primary care carries many potential benefits. It provides an opportunity to educate patients about low-risk consumption levels and the risks of excessive alcohol use. Information about the amount and frequency of alcohol consumption may inform the diagnosis of the patient's presenting condition, and it may alert clinicians to the need to advise patients whose alcohol consumption might adversely affect their use of medications and other aspects of their treatment. Screening also offers the opportunity for practitioners to take preventative measures that have proven effective in reducing alcohol-related risks. 

Development and validation of the AUDIT

The AUDIT was developed and evaluated over a period of two decades, and it has been found to provide an accurate measure of risk across gender, age and cultures. As the first screening test designed specifically for use in primary care settings, the AUDIT has the following advantages:

  • Cross-national standardization: the AUDIT was validated on primary health care patients in six countries. It is the only screening test specifically designed for international use;
  • Identifies hazardous and harmful alcohol use, as well as possible dependence;
  • Brief, rapid and flexible;
  • Designed for primary health care workers;
  • Consistent with ICD-10 definitions of alcohol dependence and harmful alcohol use;
  • Focuses on recent alcohol use.

BRIEF INTERVENTION

Brief interventions are those practices that aim to identify a real or potential alcohol problem and motivate an individual to do something about it. Brief interventions have become increasingly valuable in the management of individuals with alcohol-related problems. During the past 20 years, there have been numerous randomized trials of brief interventions in a variety of health care settings. Studies have been conducted in Australia, Bulgaria, Mexico, the United Kingdom, Norway, Sweden, the United States and many other countries. Results from these studies show that there is clear evidence that well-designed brief intervention strategies are effective, low-cost and easy to administer.

Because research has shown that brief interventions are low in cost and have proven to be effective across the spectrum of alcohol problems, health workers and policy-makers have increasingly focused on them as tools to fill the gap between the primary prevention efforts and more intensive treatment for persons with serious alcohol use disorders. It is worth noting that brief interventions are not designed to treat persons with alcohol dependence, which generally requires greater expertise and more intensive clinical management. However, they might serve well as as initial treatment for severely dependent patients seeking extended treatment.

Alongside with the companion publication on the AUDIT, WHO has also produced a manual to aid primary health care workers in administering brief interventions to persons whose alcohol consumption has become hazardous or harmful to their health. Together, these manuals describe a comprehensive approach to alcohol screening and brief intervention (SBI) that is designed to improve the health of the population and patient groups as well as individuals. 

 

Related activities:

The ASSIST project - Alcohol, Smoking and Substance Involvement Screening Test

 

 

Publications

This manual introduces the AUDIT, the Alcohol Use Disorders Identification Test, and describes how to use it to identify persons with hazardous and harmful...

Global leprosy (‎Hansen disease)‎ update, 2024: Beyond zero cases – what elimination of leprosy really means

The Global Leprosy Strategy 2021–2030,1 which is aligned with the Neglected tropical diseases road map 2021–2030,2 brings into focus the new...

Meeting of the South-East Asia Regional Working Group on Immunization

The annual meeting of the South-East (SE) Asia Regional Working Group (RWG) on Immunization was held in a hybrid format in New Delhi, India, on 7–9...

Epidemic Intelligence from Open Sources (EIOS) Strategy 2024—2026

In today’s rapidly evolving public health landscape, effective information systems are critical for timely decision-making and coordinated responses...

18th edition, Epidemiological Bulletin WHO Health Emergencies Programme WHO Regional Office for South-East Asia‎, 10 September 2025. Reporting period: 25 Aug - 07 Sep 2025

This epidemiological bulletin aims to provide the situation of key infectious diseases in the WHO South-East Asia region to inform risk assessments and...

Joint external evaluation of the International Health Regulations (‎2005)‎ core capacities of Kenya: mission report, 9–13 September 2024

The International Health Regulations (2005) (IHR) form a global framework for health security that mandates each country to build and sustain agreed...

Cancer research and development landscape: overview of 1999-2022 period 

Despite significant progress in therapeutic development, cancer is still associated with a substantial global disease burden, which is projected...

Mekong Malaria Elimination Programme epidemiology summary, volume 30, April-June 2025

The Mekong Malaria Elimination (MME) programme is an initiative aimed at supporting Greater Mekong Subregion (GMS) countries – Cambodia, Lao People's...

Malaria surveillance, monitoring and evaluation: a reference manual

This manual provides comprehensive guidance on making malaria surveillance a core intervention across all transmission settings. It positions surveillance...

Strengthening primary health care-oriented health systems to address antimicrobial resistance

A primary health care (PHC)-oriented health system aims to maximize the level and distribution of health and well-being through three components: (i) primary...

Public health resource pack for countries experiencing outbreaks of influenza in animals: revised guidance

This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the...

Vector surveillance and control at points of entry and onboard conveyances

In 2024, the total number of dengue cases worldwide reached a record high of more than 14 million, with approximately 11 000 of these cases resulting in...

WHO global water, sanitation and hygiene: annual report 2024

The WHO Results Report 2024–2025 indicates that global access to safely managed drinking-water services rose from 71.0% in 2018 to a projected 87.3%...

Routine health information system and health facility data for neglected tropical diseases: Rabies

This guidance was developed based on a template provided to health programmes by the WHO Division of Data, Analytics and Delivery for Impact. WHO disease...

WHO labour care guide: implementation resource package

The WHO Labour Care Guide advances evidence-based, respectful, and person-centered intrapartum care by strengthening health workers’ capacity for...

International travel and health: module 4: vaccine-preventable diseases and vaccines

Depending on the health profile of the traveller, the type of travel to be undertaken, and the place of transit and destination, travellers may face various...

Yaws eradication: guidance for serological surveys to assess interruption of transmision

This document summarizes guidance developed for national programmes on conducting serosurveys to assess whether interruption of yaws transmission has...

First page of a document.

“WHO’s latest global update on cholera, published in the Weekly Epidemiological Record indicates that in 2024, 60 countries reported more than...

The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification of antibiotics for evaluation and monitoring of use

The AWaRe classification is intended as a tool for monitoring antibiotic use, defining targets and monitoring the impact of stewardship policies and interventions...

The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines for Children, 10th list

Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and...

The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list

Essential medicines are those that satisfy the priority health care needs of a population. They are selected with due regard to disease prevalence and...

Related resources

The ASSIST-linked brief intervention for hazardous and harmful substance use

This manual is a companion to ‘The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care’. The...

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was developed for the World Health Organization (WHO) by an international group...

Self-help strategies for cutting down or stopping substance use (ASSIST)

Substance use problems can arise as a result of acute intoxication, regular use or dependence - and from the way in which substances are used. This guide...

Guidelines for identification and management of substance use and substance use disorders in pregnancy

These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which...

mhGAP Intervention Guide - Version 2.0

This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist...

mhGAP Training Manuals - for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings, version 2.0

As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training...

Involvement of nurses and midwives in screening and brief interventions

Psychoactive substance use can result in a wide range of health and social problems for individuals, their families and the wider community. Globally,...